PEPTIDEREPORT

Primary regulatory

LL-37 Clinical Trial Registry Entries: ClinicalTrials.gov

ClinicalTrials.gov registry search for interventional studies involving LL-37/cathelicidin, showing limited clinical trial activity. LL-37 is not FDA-approved for any indication.

ClinicalTrials.gov / U.S. National Library of MedicinePublished Jul 1, 2026Accessed Jul 1, 2026

Open original source

Registry record

Source metadata

Publisher
ClinicalTrials.gov / U.S. National Library of Medicine
Source type
Primary regulatory
Registry ID
clinicaltrials-gov-ll-37

Source usage

Linked from 6 pages

Compound

LL-37

Evidence curation

Best Peptides for Immune Support

Evidence curation

Best Peptides for Inflammation Research

Guide

FDA Enforcement Timeline: Major Actions on Peptides and Compounding

Guide

Peptide Category Explainers: How Every Compound Class on This Site Is Defined

Guide

Peptide Half-Life Reference Table

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.